Glaxo Wellcome UK Ltd.

Glaxo Wellcome is a research-based company whose people are committed to fighting disease by bringing innovative medicines and services to patients throughout the world and to the healthcare providers who serve them.
On December 27, 2000, Glaxo Wellcome and SmithKline Beecham merged to form GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies.
Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.

Activity:

- Manufacturing
- Market Research & Marketing
- Research & Development

Product / Technology type(s) covered:

- Curative
- Generics
- FP (finished products)
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins
- Prescription drugs (Rx)
- Preventive
- Technology

Therapeutic targets:

- Cancer
- Cardiovascular
- Central nervous system
- Gastrointestinal
- Infectious Diseases
- Mental Health
- Respiratory Medicine

Markets Covered

a. HeadQuarter: United Kingdom

b. Continent(s) active:

c. Countries active: Worldwide

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded:

Stock options:

	Symbol	Exchange
1	GSK	FTSE (London)
	Symbol	Exchange
2	GSK	NYSE (New York)